Skip to main content
. 2010 Jun 10;11(1):73. doi: 10.1186/1465-9921-11-73

Figure 4.

Figure 4

Influence of BMPR2 mutation types on clinical outcomes of PAH patients. Time to death or lung transplantation in BMPR2 missense mutation carriers, BMPR2 truncating mutation carriers and patients carriers of a large rearrangement or a splice defect. BMPR2: bone morphogenetic protein receptor type 2.